|
|
|
|
Drugs for sinusitis may cut off nose to spite face
The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology (ACAAI) recently updated their practice parameter, "The diagnosis and management of sinusitis," for the first time since it was originally released in 1998.
|
| |
More>>
|
|
|
|
|
|
New biologic helps those with PI help themselves
Until now, patients with primary immunodeficiency (PI) were treated with intravenous immunoglobulin (IVIg) infusions, which were inconvenient and associated with serious adverse side effects, such as migraine headaches.
|
| |
More>>
|
|
|
|
|
|
Toll-like receptors: Inflammation's missing link
Toll-like receptors (TLRs) are type I transmembrane PRRs that are now known to be essential in the recognition of the pathogen-associated molecular patterns (PAMPs) that are unique to microbes.
|
| |
More>>
|
|
|
|
|
|
Developing a 'vaccine' for melanoma
The "vaccine" approach of customizing the intervention to the patient is antithetical to the blockbuster mentality of much of the pharmaceutical industry.
|
| |
More>>
|
|
|